Instrument Inactif

Gouvernance KaloBios Pharmaceuticals Inc Nasdaq

US48344T1007

Produits pharmaceutiques

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

12/07/24	Humanigen, Inc. a cessé ses activités	CI
01/05/24	Audience combinée pour l'approbation de la déclaration d'information et du plan pour Humanigen, Inc.	CI

Comité Exécutif: KaloBios Pharmaceuticals Inc

Dirigeant

Fonctions occupéesDepuis

Cameron Durrant

65 ans

Comptroller/Controller/Auditor	23/10/2022
Chief Executive Officer	01/03/2016
Director of Finance/CFO	23/10/2022

Dale Chappell

55 ans

Chief Tech/Sci/R&D Officer

06/07/2020

Composition du Conseil d'Administration: KaloBios Pharmaceuticals Inc

Administrateur

ComitésDepuis

Cameron Durrant

65 ans

Chairman

07/01/2016

Dale Chappell

55 ans

Director/Board Member

05/02/2021

Anciens Dirigeants et Administrateurs: KaloBios Pharmaceuticals Inc

Insider

Fonctions occupées

DepuisJusqu'au

Rainer Boehm

Director/Board Member	12/02/2018	01/02/2024
Independent Dir/Board Member	12/02/2018	01/02/2024

Ronald Barliant

Director/Board Member	07/01/2016	11/10/2023
Independent Dir/Board Member	07/01/2016	11/10/2023

Edward Jordan

Corporate Officer/Principal

25/08/2020

14/09/2023

Cheryl Buxton

Director/Board Member	16/12/2019	19/07/2023
Independent Dir/Board Member	16/12/2019	19/07/2023

Timothy Morris

Director/Board Member	01/06/2016	03/08/2020
Chief Operating Officer	03/08/2020	23/10/2022
Director of Finance/CFO	03/08/2020	23/10/2022
Independent Dir/Board Member	01/06/2016	03/08/2020

Omar Ahmed

Director/Board Member	01/10/2019	-
Chief Tech/Sci/R&D Officer	07/07/2020	01/01/2022
Corporate Officer/Principal	01/10/2019	07/07/2020

Robert G. Savage

Director/Board Member	12/03/2018	01/01/2021
Independent Dir/Board Member	12/03/2018	01/01/2021

J. Gregory Jester

Director of Finance/CFO

05/09/2017

28/06/2019

Tarek Sahmoud

Chief Tech/Sci/R&D Officer

30/04/2018

Morgan Lam

Chief Operating Officer	01/02/2016	13/09/2016
Chief Tech/Sci/R&D Officer	13/09/2016	15/01/2018

Tariq Arshad

Chief Tech/Sci/R&D Officer

01/01/2016

01/01/2018

Ezra Friedberg

Director/Board Member	30/06/2016	09/11/2017
Independent Dir/Board Member	30/06/2016	09/11/2017

Niv Edward Caviar

Corporate Officer/Principal

01/09/2017

Dave Tousley

Director of Finance/CFO	14/10/2016	11/08/2017
Comptroller/Controller/Auditor	06/07/2020	05/03/2021
Corporate Secretary	06/07/2020	05/03/2021
Treasurer	06/07/2020	05/03/2021

Dean D. Witter

Director of Finance/CFO

07/01/2016

14/10/2016

David Moradi

Director/Board Member

20/11/2015

29/06/2016

Harrison Michael wayne

Director/Board Member

22/11/2015

07/01/2016

Fernandez Thomas Edward

Director/Board Member

22/11/2015

27/12/2015

Marek Biestek

Director/Board Member

20/11/2015

27/12/2015

Eugene Davis

Corporate Officer/Principal

23/12/2015

Christopher Thorn

Director of Finance/CFO

03/12/2015

21/12/2015

Tony Chase

Director/Board Member

20/11/2015

17/12/2015

Martin Shkreli

Chief Executive Officer	20/11/2015	17/12/2015
Chairman	20/11/2015	17/12/2015

Edward Painter

Investor Relations Contact	03/12/2015	-
Public Communications Contact	03/12/2015	-

Raymond M. Withy

Director/Board Member	01/07/2005	20/11/2015
Independent Dir/Board Member	01/07/2005	20/11/2015

Ronald Martell

Director/Board Member	22/04/2015	28/05/2015
Chairman	28/05/2015	20/11/2015

Denise M. Gilbert

Director/Board Member	01/01/2008	20/11/2015
Independent Dir/Board Member	01/01/2008	20/11/2015

Laurie Alsup

Director/Board Member	22/10/2013	20/11/2015
Independent Dir/Board Member	22/10/2013	20/11/2015

Robert Baffi

Director/Board Member

25/11/2014

20/11/2015

Herbert Cross

Comptroller/Controller/Auditor	01/10/2013	01/01/2015
Chief Executive Officer	01/01/2015	20/11/2015
Director of Finance/CFO	01/10/2013	20/11/2015

Gary Lyons

Director/Board Member	21/03/2011	20/11/2015
Independent Dir/Board Member	01/01/2011	20/11/2015

Ted Love

Director/Board Member	-	-
Chairman	01/05/2014	28/05/2015
Independent Dir/Board Member	01/03/2009	01/11/2015

Donald Joseph

General Counsel	17/06/2013	01/11/2015
Corporate Secretary	17/06/2013	01/11/2015

Jeanne Jew

Corporate Officer/Principal	01/04/2008	01/07/2015
Corporate Secretary	01/04/2008	-

Néstor A. Molfino

Chief Tech/Sci/R&D Officer

01/05/2012

03/02/2015

V. Lawlis

Director/Board Member

07/08/2013

01/09/2014

James Healy

Director/Board Member	01/05/2014	18/06/2014
Chairman	01/09/2001	01/05/2014
Independent Dir/Board Member	01/09/2001	01/05/2014

David W. Pritchard

Director/Board Member	01/08/2006	08/01/2014
Chief Executive Officer	01/08/2006	08/01/2014
President	01/08/2006	08/01/2014

Harry Lam

Corporate Officer/Principal

07/01/2014

Lapyuen Lam

Corporate Officer/Principal

01/01/2014

Jeffrey Cooper

Director of Finance/CFO

10/07/2012

14/10/2013

Dennis Henner

Director/Board Member	01/03/2005	23/10/2013
Independent Dir/Board Member	08/10/2012	23/10/2013

Brigitte Smith

Director/Board Member	01/06/2004	07/08/2013
Independent Dir/Board Member	01/06/2004	07/08/2013

Jonathan Leff

Sales & Marketing	01/02/2011	01/02/2012
Corporate Officer/Principal	01/01/2011	01/02/2012

Tillman E. Pearce

Chief Tech/Sci/R&D Officer

01/04/2007

01/01/2011

Thomas C. Yonker

Corporate Officer/Principal

01/03/2008

Charles J. Democko

General Counsel

01/01/2008

Edmond Mok

Comptroller/Controller/Auditor

01/04/2007

Carmen Betancourt

General Counsel

01/01/2006

01/01/2007

Geoffrey Thomas Yarranton

Director/Board Member	01/10/2006	02/10/2012
Chief Tech/Sci/R&D Officer	01/10/2006	-

Dan Shochat

Corporate Officer/Principal

01/01/2004

Robert F. Balint

Founder

16/03/2000

W. Scott Harkonen

Director/Board Member

Thomas Yonker

Corporate Officer/Principal

Nenad Tomasevic

Corporate Officer/Principal

Christopher Bebbington

Chief Tech/Sci/R&D Officer

Jeng-Horng Her

Founder

Peter D. Flynn

Corporate Officer/Principal

Al Palombo

Investor Relations Contact

Anne Borgman

Chief Tech/Sci/R&D Officer	-	-
Corporate Officer/Principal	-	-

Tolleiv Trimborn

Corporate Officer/Principal

Carin Rollins

Director/Board Member

Susan E. Light

Corporate Officer/Principal

Henk Kocken

Corporate Officer/Principal

Richard Brown

Investor Relations Contact

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	3
Femme	0

Dont comité exécutif

Homme	2
Femme	0

Dont Administrateurs

Homme	2
Femme	0

Humanigen, Inc. est une société biopharmaceutique au stade clinique. La société développe son portefeuille d'anticorps monoclonaux anti-inflammatoires et immuno-oncologiques brevetés Humaneered. Sa plateforme technologique Humaneered est une méthode de conversion d'anticorps existants (généralement murins) en anticorps humains de haute affinité conçus pour un usage thérapeutique, en particulier pour les maladies aiguës et chroniques. Son produit candidat, le lenzilumab, et son autre produit candidat, l'ifabotuzumab (iFab), sont des anticorps monoclonaux développés par Humaneered. Le lenzilumab est utilisé comme traitement de la leucémie myélomonocytaire chronique, pour la prévention de la maladie aiguë du greffon contre l'hôte et comme compagnon prophylactique de certains programmes de thérapie par récepteur antigénique chimérique (CAR-T). La société a développé des cibles ou des anticorps de recherche, généralement auprès d'institutions académiques, ou en a obtenu la licence, puis a appliqué sa technologie Humaneered pour les optimiser.

Employés

Secteur

Produits pharmaceutiques

Plus d'informations sur la société